Progressive retinal atrophy (GUCY2D-PRA)

General description

A genetic variant of the GUCY2D gene has been found to be associated with an early-onset PRA in the German Spitz. Affected dogs suffer from impaired vision under both scotopic (dim light) and photopic (bright light) conditions, already noticeable at the age of 3 months. Some of them also have oscillatory nystagmus.

Breeds

German Spitz

Order details
Test number8894
Sample material0.5 ml EDTA blood, 2x cheek swab, 1x special swab (eNAT)
Test duration7-14 working days
Test specifications
GeneGUCY2D
MutationINS
Detailed description

Progressive retinal atrophy (PRA) is a leading hereditary cause of blindness in pedigree dogs as is its counterpart retinitis pigmentosa (RP) in humans. PRA shows genetic heterogeneity, as does RP, with several distinct forms already recognized and several more remaining to be investigated. One can distinguish between late onset forms of PRA and early onset (whelp-age) dysplastic changes. The clinical and ophthalmologic signs of both forms are similar. Affected dogs suffer from bilateral Mydriasis, the reflection of the Tapetum lucidum is increased and the retinal vascular network appears atrophic.\n\nA genetic variant of the GUCY2D gene has been found to be associated with an early-onset PRA in the breed German Spitz. Affected dogs suffer from impaired vision under both scotopic (dim light) and photopic (bright light) conditions, already noticeable at the age of 3 months. They show pale papilla and mild vascular attenuation. Some of them also have oscillatory nystagmus. While the photoreceptor function is already severely impaired or absent after a few months of age, the retinal structure is initially well-preserved. Only in older affected animals, a slight retinal thinning could be observed. \n


Ihr Experte für Tiergenetik!

Зв'яжіться з нами

LABOGEN – це пропозиція від
LABOKLIN GMBH & CO.KG
ЛАБОРАТОРІЯ КЛІНІЧНОЇ ДІАГНОСТИКИ

… де досвід поєднується з якістю!

Copyright © 2024 LABOGEN by LABOKLIN. All Rights Reserved.

This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.